fenofibrate has been researched along with Cardiac Output, Low in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenofibrate treatment blunted reduction in left ventricular ejection fraction, reduced cardiac hypertrophy, and attenuated clinical signs of heart failure." | 5.34 | The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy. ( Brigadeau, F; Duriez, P; Fruchart, JC; Gelé, P; Lacroix, D; Marquié, C; Martin-Nizard, F; Staels, B; Torpier, G; Wibaux, M, 2007) |
| "Fenofibrate treatment blunted reduction in left ventricular ejection fraction, reduced cardiac hypertrophy, and attenuated clinical signs of heart failure." | 1.34 | The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy. ( Brigadeau, F; Duriez, P; Fruchart, JC; Gelé, P; Lacroix, D; Marquié, C; Martin-Nizard, F; Staels, B; Torpier, G; Wibaux, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogata, T | 1 |
| Miyauchi, T | 1 |
| Sakai, S | 1 |
| Takanashi, M | 1 |
| Irukayama-Tomobe, Y | 1 |
| Yamaguchi, I | 1 |
| Brigadeau, F | 1 |
| Gelé, P | 1 |
| Wibaux, M | 1 |
| Marquié, C | 1 |
| Martin-Nizard, F | 1 |
| Torpier, G | 1 |
| Fruchart, JC | 1 |
| Staels, B | 1 |
| Duriez, P | 1 |
| Lacroix, D | 1 |
2 other studies available for fenofibrate and Cardiac Output, Low
| Article | Year |
|---|---|
Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with
Topics: Animals; Blotting, Western; Cardiac Output, Low; Desoxycorticosterone; Diastole; Fenofibrate; Fibros | 2004 |
The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.
Topics: Acyl-CoA Oxidase; Animals; Atrial Natriuretic Factor; Biomarkers; Cardiac Output, Low; Cardiomyopath | 2007 |